Interleukin-12 (IL-12) is a proinflammatory cytokine that initiates antitumor immune responses by promoting the generation of tumor-specific cytotoxic T lymphocytes (CTLs) and activating natural killer (NK) cells and CD4+ T cells (131, 132). Here, CD4 is linked to neoplasm.